PHILIP J. MEASE, M.D.; ALLAN J. ELLSWORTH, PHARM.D.; PAUL D. KILLEN, M.D.; ROBERT F. WILLKENS, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: We report severe renal failure and nephrotic syndrome in three patients taking zomepirac sodium, a nonsteroidal anti-inflammatory drug.
A 46-year-old woman who had been taking zomepirac sodium for 2 months for headache developed renal failure and nephrotic syndrome. Laboratory studies showed creatinine, 3.9 mg/dL; blood urea nitrogen, 90 mg/dL; albumin, 1.4 mg/dL; and 24-hour urine protein, 14.5 g. Renal biopsy showed tubular cell vacuolization with sloughing of tubular cells and interstitial edema with a pleomorphic infiltrate. Results of immunofluorescent studies were normal. Zomepirac was withdrawn and prednisone, 60 mg/d, was instituted. Renal failure and nephrotic syndrome resolved
MEASE PJ, ELLSWORTH AJ, KILLEN PD, et al. Zomepirac, Interstitial Nephritis, and Renal Failure. Ann Intern Med. 1982;97:454. doi: https://doi.org/10.7326/0003-4819-97-3-454_1
Download citation file:
Published: Ann Intern Med. 1982;97(3):454.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use